{"id":609,"date":"2021-05-17T13:27:37","date_gmt":"2021-05-17T11:27:37","guid":{"rendered":"https:\/\/web.penta-pco.com\/toraks2021\/?page_id=609"},"modified":"2021-05-22T10:11:47","modified_gmt":"2021-05-22T08:11:47","slug":"program-lijecnici-javno","status":"publish","type":"page","link":"https:\/\/web.penta-pco.com\/toraks2021\/program-lijecnici-javno\/","title":{"rendered":"PROGRAM LIJE\u010cNICI"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"609\" class=\"elementor elementor-609\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-304e668 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"304e668\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1510fc8\" data-id=\"1510fc8\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2366f13 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"2366f13\" data-element_type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/web.penta-pco.com\/toraks2021\/wp-content\/uploads\/2021\/05\/Toraks-2021_Finalni-program_Final-programme.pdf\" target=\"_blank\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-file-pdf\"><\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Finalni program kongresa preuzmite ovdje <\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6ed5084 elementor-tabs-view-horizontal elementor-widget elementor-widget-tabs\" data-id=\"6ed5084\" data-element_type=\"widget\" data-widget_type=\"tabs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-tabs\">\n\t\t\t<div class=\"elementor-tabs-wrapper\" role=\"tablist\" >\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1161\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"elementor-tab-content-1161\" aria-expanded=\"false\">Srijeda 19.5<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1162\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1162\" aria-expanded=\"false\">\u010cetvrtak 20.5<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1163\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1163\" aria-expanded=\"false\">Petak 21.5<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1164\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1164\" aria-expanded=\"false\">Subota 22.5<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"elementor-tabs-content-wrapper\" role=\"tablist\" aria-orientation=\"vertical\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"elementor-tab-content-1161\" aria-expanded=\"false\">Srijeda 19.5<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1161\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1161\" tabindex=\"0\" hidden=\"false\"><table><tbody><tr><td width=\"20%\">\u00a0<\/td><td width=\"80%\"><strong><span style=\"color: #0062af;\">Srijeda, 19. Svibnja 2021. | Wednesday, May 19th 2021<br \/>Voditelji | Chairpersons: Latinka Basara, Gordana Pavli\u0161a, Nevenka Piska\u010d-\u017divkovi\u0107, Jo\u0161ko \u0160emni\u010dki, \u017deljko \u010culina, Vilim Kolari<br \/><\/span><\/strong><\/td><\/tr><tr><td style=\"text-align: center;\">15:00-15:10<\/td><td>\u017darko Vrbica<br \/><span style=\"color: #0062af;\">\u0160to mo\u017eemo nau\u010diti o egzacerbacijama KOPB u vrijeme pandemije COVID-19?<\/span><br \/>What we can learn about COPD exacerbations during COVID-19 pandemic?<\/td><\/tr><tr><td style=\"text-align: center;\">15:10-15:20<\/td><td>Nevenka Piska\u010d \u017divkovi\u0107<br \/><span style=\"color: #0062af;\">COVID-19 pneumonija i lije\u010denje visokim protokom kisika<br \/><\/span>COVID-19 pneumonia and High flow oxygen therapy (HFOT)<\/td><\/tr><tr><td style=\"text-align: center;\">15:20-15:30<\/td><td>Gordana Pavli\u0161a<br \/><span style=\"color: #0062af;\">Neutraliziraju\u0107a protutijela i konvalescentna plazma u lije\u010denju COVID-19 bolesti<\/span><br \/>Antiviral drugs and direct inhibitors in COVID-19 treatment<\/td><\/tr><tr><td style=\"text-align: center;\">15:30-15:40<\/td><td>Ana-Marija \u0160ola, Dina Rnjak<br \/><span style=\"color: #0062af;\">Covid infekcija u pacijenata sa transplantiranim plu\u0107ima<\/span><br \/>Neutralizing antibodies and convalescent plasma in the treatment of COVID-19 disease<\/td><\/tr><tr><td style=\"text-align: center;\">15:45-15:55<\/td><td>Ana He\u0107imovi\u0107<br \/><span style=\"color: #0062af;\">Kortikosteroidi u lije\u010denju COVID-19 infekcije \u2013 znamo li kada i koliko dugo?<\/span><br \/>Corticosteroids in treatment of COVID-19 infection \u2013 do we know when and for how long?<\/td><\/tr><tr><td style=\"text-align: center;\">15:55-16:05<\/td><td>Marinko Artukovi\u0107, Tomislav Perkovi\u0107<br \/><span style=\"color: #0062af;\">Alergijske reakcije na cjepiva i cijepljenje alergi\u010dara protiv COVID-19 bolesti<\/span><br \/>Allergic reactions to vaccines and vaccination of allergy patients with COVID-19 vaccine<\/td><\/tr><tr><td style=\"text-align: center;\">16:05-16:15<\/td><td>Mateja Jankovi\u0107 Makek<br \/><span style=\"color: #0062af;\">Post-COVID sindrom \u2013 pregled osnovnih pojmova<br \/><\/span>Post-COVID syndrome \u2013 overview of basic concepts<\/td><\/tr><tr><td style=\"text-align: center;\">16:15-16:25<\/td><td>Sanda \u0160krinjari\u0107-Cincar<br \/><span style=\"color: #0062af;\">Hiperventilacija u simptomatskih bolesnika nakon akutnog COVID-19<br \/><\/span>Hyperventilation in symptomatic patients after acute COVID-19<\/td><\/tr><tr><td style=\"text-align: center;\">16:25-16:35<\/td><td>Fed\u017ea D\u017eubur<br \/><span style=\"color: #0062af;\">Plu\u0107na embolija kod post-COVID-19 bolesnika<br \/><\/span>Pulmonary embolism in post-COVID-19 patients<\/td><\/tr><tr><td style=\"text-align: center;\">16:35-16:45<\/td><td>Tajana Jalu\u0161i\u0107 Glun\u010di\u0107<br \/><span style=\"color: #0062af;\">Post-COVID i plu\u0107na rehabilitacija<br \/><\/span>Post-COVID and pulmonology rehabilitation<\/td><\/tr><tr><td style=\"text-align: center;\">16:45-16:55<\/td><td>Goran Glodi\u0107<br \/><span style=\"color: #0062af;\">Prikaz slu\u010daja: Ekstrakorporalna membranska oksigenacija (ECMO) u kasnoj fazi akutne COVID-19 bolesti<\/span><br \/>Case report: Extracorporeal membrane oxygenation (ECMO) in late stage acute COVID-19 disease<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF!important; color: #fff;\">17:00-18:00<\/td><td style=\"background: #0062AF!important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Berlin \u2013 Chemie<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Moderator: Miroslav Samar\u017eija<\/span><\/p><p>Andrea Vuki\u0107 Dugac<br \/><span style=\"color: #0062af;\">Utjecaj pandemije COVID-19 na fizi\u010dku aktivnost KOPB bolesnika<\/span><br \/>Impact of the COVID-19 pandemic on the physical activity of COPD patients<\/p><p>Fed\u017ea D\u017eubur<br \/><span style=\"color: #0062af;\">Edoksaban u lije\u010denju duboke venske tromboze (DVT) i plu\u0107ne embolije (PE) te prevenciji ponavljaju\u0107ih DVT-a i PE-a u odraslih: Pivotalno ispitivanje Hokusai-VTE<\/span><br \/>Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults: Pivotal study of Hokusai-VTE<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">18:00-18:45<\/td><td style=\"background: #0062AF!important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Pfizer<\/td><\/tr><tr><td>\u00a0<\/td><td><p>Gordana Pavli\u0161a<br \/><span style=\"color: #0062af;\">Izavukonazol \u2013 preemptivne mogu\u0107nosti terapije invazivne aspergiloze i mukormikoze<\/span><br \/>Isavuconazole Pre-emptive treatment options for invasive aspergillosis and mucormycosis<\/p><p>Dra\u017eena Srdi\u0107<br \/><span style=\"color: #0062af;\">Tromboembolijske komplikacije u onkolo\u0161kih bolesnika \u2013 \u0161to mo\u017eemo u\u010diniti?<\/span><br \/>Tromboembolic complications in cancer patients \u2013 what can we do ?<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">18:50-19:20<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Alkaloid<\/td><\/tr><tr><td>\u00a0<\/td><td>Zagorka Boras<br \/><span style=\"color: #0062af;\">Fovelid (levofloxacin) \u2013 kada, kome i za\u0161to?<br \/><\/span>Fovelid (levofloxacin) \u2013 when, whom and why?<\/td><\/tr><tr><td style=\"text-align: center;\">19:20<\/td><td><span style=\"color: #0062af;\">Otvaranje kongresa <\/span>| Opening ceremony<\/td><\/tr><\/tbody><\/table><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1162\" aria-expanded=\"false\">\u010cetvrtak 20.5<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1162\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1162\" tabindex=\"0\" hidden=\"hidden\"><table><tbody><tr><td width=\"20%\">\u00a0<\/td><td width=\"80%\"><strong><span style=\"color: #0062af;\">\u010cetvrtak, 20. svibnja 2021. | Thursday, May 20th 2021<br \/>Voditelji | Chairpersons: Sanja Popovi\u0107 Grle, Ivan Gudelj, Robert Paro Vidolin, Marinko Artukovi\u0107, \u017darko Vrbica<br \/><\/span><\/strong><\/td><\/tr><tr><td style=\"text-align: center;\">09:00-09:20<\/td><td>Bojana Butorac-Petanjek<br \/><span style=\"color: #0062af;\">Global Lung Function Initiative (GLI) referentne vrijednosti za testove plu\u0107ne funkcije<\/span><br \/>Global Lung Function Initiative (GLI) reference values for pulmonary function tests<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">09:20-09:50<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Swixx Biopharma<\/td><\/tr><tr><td>\u00a0<\/td><td>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">Respiracijske alergije \u2013 prilike za etiolo\u0161ko lije\u010denje<br \/><\/span>Respiratory allergies \u2013 opportunities for etiological treatment<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">09:50-10:35<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Berlin \u2013 Chemie<\/td><\/tr><tr><td>\u00a0<\/td><td><p>Radovan Zrili\u0107<br \/><span style=\"color: #0062af;\">Terapija odr\u017eavanja kod bolesnika s trajnom astmom<br \/><\/span>Maintenance therapy in patients with persistent asthma<\/p><p>Dino Ilak<br \/><span style=\"color: #0062af;\">Klini\u010dki aspekt lije\u010denja KOPB-a trojnom fiksnom kombinacijom IKS\/LABA\/LAMA<br \/><\/span>Clinical aspect of COPD treatment with triple fixed combination ICS\/LABA\/LAMA<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">10:40-11:10<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Berlin \u2013 Chemie<\/td><\/tr><tr><td>\u00a0<\/td><td>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">\u010cetiri godine iskustva u lije\u010denju te\u0161ke eozinofilne astme<br \/><\/span>Four years of experience in the treatment of severe eosinophilic asthma<\/td><\/tr><tr><td style=\"text-align: center;\">11:10-11:30<\/td><td><span style=\"color: #0062af;\">Pauza<\/span> | Break<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">11:30-12:30<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by AstraZeneca<\/td><\/tr><tr><td>\u00a0<\/td><td><p>Jelena Ostoji\u0107 i Andrea Vuki\u0107 Dugac<br \/><span style=\"color: #0062af;\">Trixeo \u2013 tre\u0107a sre\u0107a<br \/><\/span>Trixeo \u2013 third luck<\/p><p><span style=\"color: #0062af;\">Stav hrvatskih pulmologa o biolo\u0161kim lijekovima za astmu, mo\u017eemo li bolje?<br \/><\/span>The attitude of Croatian pulmonologists about biological drugs for asth- ma, can we do better?<\/p><p>Neven Tudori\u0107<br \/><span style=\"color: #0062af;\">Biologici u te\u0161koj astmi \u2013 gdje smo i mo\u017eemo li bolje?<br \/><\/span>Biologics in severe asthma \u2013 where we are now and how to get better?<\/p><p>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">Rezultati istra\u017eivanja o primjeni biolo\u0161ke terapije u Hrvatskoj<br \/><\/span>Results of research on use of biological therapy in Croatia<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">12:30-13:30<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by PLIVA<\/td><\/tr><tr><td>\u00a0<\/td><td><p>Jelena Ostoji\u0107, \u017darko Vrbica<br \/><span style=\"color: #0062af;\">Adherencija u bolesnika s opstruktivnim plu\u0107nim bolestima: ju\u010der, danas, sutra<br \/><\/span>Adherence in patients with obstructive lung diseases: yesterday, today, tomorrow<\/p><p>Andrea Vuki\u0107 Dugac<br \/><span style=\"color: #0062af;\">Rani KOPB \u2013 igra skriva\u010da?<br \/><\/span>Early COPD \u2013 hide and seek?<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">13:35-14:05<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Boehringer Ingelheim<\/td><\/tr><tr><td>\u00a0<\/td><td>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">Dispnea i KOPB \u2013 prepoznavanje ranih simptoma bolesti<br \/><\/span>Dyspnoea and COPD \u2013 recognition of the early symptoms of disease<\/td><\/tr><tr><td style=\"text-align: center;\">14:05-15:00<\/td><td><span style=\"color: #0062af;\">Pauza<\/span> | Break<\/td><\/tr><tr><td>\u00a0<\/td><td><strong><span style=\"color: #0062af;\">Voditelji | Chairpersons: Ljiljana Bulat-Kardum, Marija Gomer\u010di\u0107 Pal\u010di\u0107, Tajana Jalu\u0161i\u0107 Glun\u010di\u0107, Sanda \u0160krinjari\u0107-Cincar<br \/><\/span><\/strong><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">15:00-16:00<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Providens<\/td><\/tr><tr><td style=\"text-align: center;\">\u00a0<\/td><td><p><span style=\"color: #0062af;\">Moderator: Miroslav Samar\u017eija<\/span><\/p><p><span style=\"color: #0062af;\">\u201cSitno je bitno\u201d \u2013 nova paradigma<br \/><\/span>It\u2019s the little things that matter the most \u2013 a new paradigm<\/p><p>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">ATLANTIS \u2013 putokaz u lije\u010denju astme<br \/><\/span>ATLANTIS \u2013 a roadmap in the treatment of asthma<\/p><p>Dave Singh<br \/><span style=\"color: #0062af;\">Trojna fiksna terapija s vrlo sitnim \u010desticama \u2013 dobitna kombinacija<br \/><\/span>Triple fixed therapy with extrafine particles \u2013 a winning combination<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">16:00-16:45<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Novartis<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Primjeri iz svakodnevne klini\u010dke prakse u lije\u010denju te\u0161ke alergijske astme<br \/><\/span>Examples from everyday clinical practice in treatment of severe allergic asthma<\/p><p>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">Jedino anti-IgE protutijelo dostupno za lije\u010denje te\u0161ke alergijske astme<br \/><\/span>The only anty-IgE antibody in treatment of severe allergic asthma<\/p><p>Marina Lampalo<br \/><span style=\"color: #0062af;\">Vi\u0161egodi\u0161nje iskustvo u klini\u010dkoj primjeni i sigurnosni profil lijeka Xolair<br \/><\/span>Clinical application and safety profile of Xolair \u2013 our experinece<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">16:50-17:20<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by PLIVA<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Biolo\u0161ka terapija te\u0161ke astme<br \/><\/span>Severe asthma and biologic therapy<\/p><p>Sanja Popovi\u0107 Grle<br \/><span style=\"color: #0062af;\">Kako procijeniti odgovor bolesnika?<br \/><\/span>How to evaluate the response?<\/p><p>Marina Lampalo<br \/><span style=\"color: #0062af;\">Ishodi u klini\u010dkoj praksi<br \/><\/span>Outcomes in clinical practice<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">17:20-18:20<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Medis Adria<\/td><\/tr><tr><td>\u00a0<\/td><td><p>Marija Gomer\u010di\u0107 Pal\u010di\u0107<br \/><span style=\"color: #0062af;\">Uloga visokih doza inhalacijskih kortikosteroida u lije\u010denju astme<br \/><\/span>The role of high dose of ICS in the treatment of asthma<\/p><p>Mirjana Turkalj<br \/><span style=\"color: #0062af;\">Nezadovoljene potrebe u astmi: Trebamo li nove inovativne kombinacije?<br \/><\/span>Unmeet need in asthma: Do we need new innovative combinations?<\/p><p>Fed\u017ea D\u017eubur<br \/><span style=\"color: #0062af;\">Va\u017enost redukcije dana hospitalizacije PAH pacijenata u vrijeme pandemije<br \/><\/span>Importance of reduction in hospitalisation days of PAH patients in a time of pandemic<\/p><\/td><\/tr><tr><td style=\"text-align: center;\">18:20-18:35<\/td><td>Ana He\u0107imovi\u0107<br \/><span style=\"color: #0062af;\">Tadalafil \u2013 nova terapijska opcija u lije\u010denju PAH-a<\/span><br \/>Tadalafil \u2013 a new therapeutic option in the treatment of PAH<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">18:40-19:25<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by MSD<\/td><\/tr><tr><td>\u00a0<\/td><td>Irene M. Lang Barbara Salobir Miroslav Samar\u017eija<br \/><span style=\"color: #0062af;\">Izazovi u dijagnostici i terapijskim rje\u0161enjima u lije\u010denju KTEPH-a i PAH-a<br \/><\/span>Challenges in diagnostics and therapeutic solutions in the treatment of CTEPH and PAH<\/td><\/tr><\/tbody><\/table><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1163\" aria-expanded=\"false\">Petak 21.5<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1163\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1163\" tabindex=\"0\" hidden=\"hidden\"><table><tbody><tr><td width=\"20%\">\u00a0<\/td><td width=\"80%\"><strong><span style=\"color: #0062af;\">Petak, 21. svibnja 2021. | Friday, May 21st 2021<br \/>Voditelji | Chairpersons: Lovorka Batelja Vuleti\u0107, Dra\u017eena Srdi\u0107, Suzana Mladinov, Milena Peitl, Sanja Ple\u0161tina<br \/><\/span><\/strong><\/td><\/tr><tr><td style=\"text-align: center;\">09:00-09:20<\/td><td>Ante Maru\u0161i\u0107<br \/><span style=\"color: #0062af;\">Nacionalni program probira i ranog otkrivanja raka plu\u0107a \u2013 prva iskustva<br \/><\/span>Nationwide lung cancer screening program \u2013 first experiences<\/td><\/tr><tr><td style=\"text-align: center;\">09:20-09:40<\/td><td>Silvana Smojver-Je\u017eek<br \/><span style=\"color: #0062af;\">Nove smjernice za uzimanje i obradu torakalnih malih biopsija i citolo\u0161kih uzoraka i njihov utjecaj na rad citologija<br \/><\/span>New Guidelines for Collection and Handling of Thoracic Small Biopsy and Cytology Specimens and Implications for the Cytology Community<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">09:40-10:00<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Medical symposium sponsored by Roche<\/td><\/tr><tr><td>\u00a0<\/td><td>Miroslav Samar\u017eija<br \/><span style=\"color: #0062af;\">Budu\u0107nost lije\u010denja raka plu\u0107a<br \/><\/span>The Future of Lung Cancer Treatment<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">10:00-10:30<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Takeda<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Dijagnostika i lije\u010denje ALK+ raka plu\u0107a te raka plu\u0107a s insercijskim mutacijama u egzonu 20 EGFR gena<br \/><\/span>Diagnostics and treatment of ALK+ lung cancer, and lung cancer harboring EGFR exon20 insertion mutations<\/p><p>Miroslav Samar\u017eija<br \/><span style=\"color: #0062af;\">Biologija i prognoza ALK+ raka plu\u0107a te raka plu\u0107a s insercijskim mutacijama u egzonu 20 EGFR gena<\/span><br \/>Biology and prognosis of ALK positive lung cancer, and lung cancer harboring EGFR exon 20 insertion mutations<\/p><p>Marko Jakopovi\u0107<br \/><span style=\"color: #0062af;\">Klini\u010dke odluke u lije\u010denju bolesnika s ALK+ rakom plu\u0107a<\/span><br \/>Clinical decisions in the treatment ALK+ lung cancer patients<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">10:30-11:15<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Pfizer<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Izazovi u lije\u010denju bolesnika s ALK+ i ROS1+ rakom plu\u0107a nemalih stanica<br \/><\/span>Treatment challenges of patients with ALK + and ROS1 + non-small cell lung cancer<\/p><p>Marko Jakopovi\u0107<br \/><span style=\"color: #0062af;\">Ishodi lije\u010denja bolesnika s ALK+ rakom plu\u0107a nemalih stanica \u2013 mo\u017ee li bolje?<\/span><br \/>Treatment outcomes of patients with ALK + NSCLC \u2013 could it be better?<\/p><p>Sanja Ple\u0161tina<br \/><span style=\"color: #0062af;\">Lorviqua (lorlatinib) \u2013 sljede\u0107a linija lije\u010denja bolesnika s ALK+ rakom plu\u0107a nemalih stanica<\/span><br \/>Lorviqua (lorlatinib) \u2013 the next line of treatment for patients with ALK + NSCLC<\/p><p>Sonja Badovinac<br \/><span style=\"color: #0062af;\">Izazovi u lije\u010denju bolesnika s ROS1+ rakom plu\u0107a nemalih stanica<\/span><br \/>Challenges in the treatment of patients with ROS1 + NSCLC<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">11:15-11:45<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Boehringer Ingelheim<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Moderator: Marko Jakopovi\u0107<\/span><\/p><p>Marko Jakopovi\u0107<br \/><span style=\"color: #0062af;\">Nintedanib u okviru trenutnih terapijskih opcija kod adenokarcinoma plu\u0107a<br \/><\/span>Nintedanib in the light of therapeutical options for lung adenocarcinoma<\/p><p>Marta Kor\u0161i\u0107<br \/><span style=\"color: #0062af;\">Produ\u017eimo vrijeme bez kemoterapije bolesnicima s NSCLC EGFR+<br \/><\/span>Let\u2019s prolong the time without chemotherapy for patients with NSCLC EGFR+<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">11:45-12:15<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium sponsored by Roche<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Pravi lijek za pravog bolesnika u pravo vrijeme \u2013 kako nam FoundationOne mo\u017ee pomo\u0107i?<br \/><\/span>The right treatment for the right patient at the right time \u2013 how can FoundationOne help us?<\/p><p><span style=\"color: #0062af;\">Moderator: Marko Jakopovi\u0107<\/span><\/p><p>Sonja Badovinac<br \/><span style=\"color: #0062af;\">Preduvjeti za uspje\u0161no FoundationOne testiranje<br \/><\/span>Prerequisites for successful FoundationOne testing<\/p><p>Kristina Krpina<br \/><span style=\"color: #0062af;\">\u0160to nam je FoundationOne otkrio u praksi-iskustva Klinike za plu\u0107ne bolesti Jordanovac<br \/><\/span>What FoundationOne revealed to us in practice-experiences of the Clinic for Lung Diseases Jordanovac<\/p><\/td><\/tr><tr><td style=\"text-align: center;\">12:15-13:30<\/td><td><span style=\"color: #0062af;\">Pauza<\/span> | Break<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">13:30-14:30<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by MSD<\/td><\/tr><tr><td style=\"text-align: center;\">\u00a0<\/td><td>Miroslav Samar\u017eija, Marko Jakopovi\u0107, Tihana Boraska Jelavi\u0107<br \/><span style=\"color: #0062af;\">Redefiniranje o\u010dekivanja pre\u017eivljenja za bolesnike s rakom plu\u0107a<br \/><\/span>Redefining survival expectations for lung cancer patients<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">14:30-15:00<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by AstraZeneca<\/td><\/tr><tr><td>\u00a0<\/td><td>Marko Jakopovi\u0107, Jo\u0161ko Juri\u010di\u0107<br \/><span style=\"color: #0062af;\">Mo\u017eemo li unaprijediti lije\u010denje resektabilnog raka plu\u0107a nemalih stanica<br \/><\/span>Can we improve treatment of resectable NSCLC<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">15:05-15:50<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by BMS<\/td><\/tr><tr><td>\u00a0<\/td><td>Miroslav Samar\u017eija, Marijo Boban, Marko Jakopovi\u0107<br \/><span style=\"color: #0062af;\">Imunoterapija kod uznapredovalih torakalnih karcinoma<br \/><\/span>Immunotherapy in advanced thoracic cancers<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">15:50-16:35<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium sponsored by Roche<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Standardi u lije\u010denju pro\u0161irenog raka plu\u0107a<br \/><\/span>Standards in metastatic lung cancer treatment<\/p><p><span style=\"color: #0062af;\">Moderator: Marko Jakopovi\u0107<\/span><\/p><p>Sanja Ple\u0161tina<br \/><span style=\"color: #0062af;\">ALECENSA\u00ae i ROZLYTREK\u00ae: standard u prvoj liniji lije\u010denja bolesnika s ALK+ i ROS1+ NSCLC-om<br \/><\/span>ALECENSA\u00ae and ROZLYTREK\u00ae: standard in the first line of ALK+ and ROS1+ NSCLC treatment<\/p><p>Ana Ba\u010deli\u0107 Gabelica<br \/><span style=\"color: #0062af;\">TECENTRIQ\u00ae u drugolinijskom lije\u010denju raka plu\u0107a nemalih stanica<br \/><\/span>TECENTRIQ\u00ae in the second line treatment of NSCLC<\/p><p>Marta Kor\u0161i\u0107<br \/><span style=\"color: #0062af;\">TECENTRIQ\u00ae u lije\u010denju raka plu\u0107a malih stanica<br \/><\/span>TECENTRIQ\u00ae in the small-cell lung cancer treatment<\/p><p>Marko Jakopovi\u0107<br \/><span style=\"color: #0062af;\">TECENTRIQ\u00ae u monoterapiji prvolinijskog lije\u010denja raka plu\u0107a nemalih stanica<br \/><\/span>TECENTRIQ\u00ae monotherapy in the first line treatment of NSCLC<\/p><\/td><\/tr><\/tbody><\/table><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1164\" aria-expanded=\"false\">Subota 22.5<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1164\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"4\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1164\" tabindex=\"0\" hidden=\"hidden\"><table><tbody><tr><td width=\"20%\">\u00a0<\/td><td width=\"80%\"><strong><strong><span style=\"color: #0062af;\">Subota, 22. svibnja 2021. | Saturday, May 22nd 2021<br \/>Voditelji | Chairpersons: Zoran Janevski, Fed\u017ea D\u017eubur, \u0110ivo Ljubi\u010di\u0107, Igor Barkovi\u0107, Miroslav Samar\u017eija<\/span><\/strong><\/strong><\/td><\/tr><tr><td style=\"text-align: center;\">09:00-09:10<\/td><td>Dorian Hir\u0161l<br \/><span style=\"color: #0062af;\">Prva bilateralna transplantacija plu\u0107a u Hrvatskoj \u2013 prvi dio<br \/><\/span>First bilateral lung transplantation in Croatia \u2013 part one<\/td><\/tr><tr><td style=\"text-align: center;\">09:10-09:20<\/td><td>Tomislav Kopjar<br \/><span style=\"color: #0062af;\">Prva bilateralna transplantacija plu\u0107a u Hrvatskoj \u2013 drugi dio<br \/><\/span>First bilateral lung transplantation in Croatia \u2013 part two<\/td><\/tr><tr><td style=\"text-align: center;\">09:20-09:30<\/td><td>Dina Rnjak<br \/><span style=\"color: #0062af;\">Novi lijekovi u pulmologiji<br \/><\/span>New drugs in pulmonology<\/td><\/tr><tr><td style=\"text-align: center;\">09:30-09:50<\/td><td>Andrea Vuki\u0107 Dugac<br \/><span style=\"color: #0062af;\">Projekt \u201c\u0160kola ka\u0161lja\u201d \u2013 rezultati istra\u017eivanja i predstavljanje algoritama za lije\u010denje ka\u0161lja<br \/><\/span>&#8220;Cough school&#8221; project \u2013 results of survey and presentation of cough treatment algorithm<\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">09:55-10:40<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran Symposium sponsored by Roche<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Pirfenidone \u2013 ju\u010der, danas, sutra<br \/><\/span>Pirfenidone \u2013 yesterday, today, tomorrow<\/p><p><span style=\"color: #0062af;\">Moderator: Miroslav Samar\u017eija<\/span><\/p><p>Ana He\u0107imovi\u0107<br \/><span style=\"color: #0062af;\">10 godina pirfenidona u klini\u010dkoj praksi<\/span><br \/>Ten years of Pirfenidone in clinical practice<\/p><p>Jasna Tekavec Trkanjec<br \/><span style=\"color: #0062af;\">Primjena Pirfenidona u fibroziraju\u0107im plu\u0107nim bolestima<\/span><br \/>Use of Pirfenidone in fibrosing lung disease<\/p><\/td><\/tr><tr><td style=\"text-align: center; background: #0062AF !important; color: #fff;\">10:40-11:25<\/td><td style=\"background: #0062AF !important; color: #fff;\">Simpozij \u2013 Sponzoriran<br \/>Symposium Sponsored by Boehringer Ingelheim<\/td><\/tr><tr><td>\u00a0<\/td><td><p><span style=\"color: #0062af;\">Moderator: Miroslav Samar\u017eija<\/span><\/p><p>Miroslav Samar\u017eija<br \/><span style=\"color: #0062af;\">Intersticijske bolesti plu\u0107a, poznato i nepoznato \u2013 uvod<\/span><br \/>Interstitial lung diseases, known and unknown<\/p><p>Jasna Tekavec Trkanjec<br \/><span style=\"color: #0062af;\">Nintedanib u lije\u010denju progresivnih fibroziraju\u0107ih intersticijskih bolesti plu\u0107a<\/span><br \/>Nintedanib for the treatment of progressive fibrosing interstitial lung diseases<\/p><p>Ana He\u0107imovi\u0107<br \/><span style=\"color: #0062af;\">Za\u0161to nintedanib u IPF-u<\/span><br \/>Why nintedanib in IPF<\/p><\/td><\/tr><tr><td>\u00a0<\/td><td><strong><span style=\"color: #0062af;\">Voditelji | Chairpersons: Suzana Kukulj, Gordana Pavli\u0161a, Mateja Jankovi\u0107 Makek, Irena Godi\u0107<\/span><\/strong><\/td><\/tr><tr><td>11:25-11:35<\/td><td><span style=\"color: #0062af;\">Nagrada za najbolje postere<\/span><br \/>Best poster awards<\/td><\/tr><\/tbody><\/table><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Finalni program kongresa preuzmite ovdje Srijeda 19.5 \u010cetvrtak 20.5 Petak 21.5 Subota 22.5 Srijeda 19.5 \u00a0 Srijeda, 19. Svibnja 2021. | Wednesday, May 19th 2021Voditelji | Chairpersons: Latinka Basara, Gordana Pavli\u0161a, Nevenka Piska\u010d-\u017divkovi\u0107, Jo\u0161ko \u0160emni\u010dki, \u017deljko \u010culina, Vilim Kolari 15:00-15:10 \u017darko Vrbica\u0160to mo\u017eemo nau\u010diti o egzacerbacijama KOPB u vrijeme pandemije COVID-19?What we can learn about [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":7,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-609","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/pages\/609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/comments?post=609"}],"version-history":[{"count":40,"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/pages\/609\/revisions"}],"predecessor-version":[{"id":1112,"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/pages\/609\/revisions\/1112"}],"wp:attachment":[{"href":"https:\/\/web.penta-pco.com\/toraks2021\/wp-json\/wp\/v2\/media?parent=609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}